Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tam, A. S.
Right arrow Articles by Massey, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tam, A. S.
Right arrow Articles by Massey, T. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 24, No. 1, 121-132, January 2003
© 2003 Oxford University Press


CARCINOGENESIS

Perturbations of the Ink4a/Arf gene locus in aflatoxin B1-induced mouse lung tumors

Andrew S. Tam1, Theodora R. Devereux2, Arti C. Patel4, Julie F. Foley3, Robert R. Maronpot3 and Thomas E. Massey1,5

1 Queen’s University, Department of Pharmacology and Toxicology, Kingston, Ontario K7L 3N6, Canada,
2 Laboratory of Molecular Carcinogenesis,
3 Laboratory of Experimental Pathology, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA and
4 National Cancer Institute, 6130 Executive Boulevard, Suite 3109, Bethesda, MD 20892-7361, USA

Lung tumors from AC3F1 mice treated with aflatoxin B1 (AFB1), were examined for loss of alleles, point mutations and hypermethylation of CpG sites within the promoters of the two genes in the Ink4a/Arf gene locus. Loss of microsatellite alleles in the Ink4a/Arf region occurred in 22 of 74 (30%) AFB1-induced lung tumors. Fifty-one of 61 (83%) tumors had at least partial methylation of CpG sites within the p16Ink4a promoter-exon 1{alpha} region. At least partial methylation of CpG sites was observed in 43 of 49 (88%) tumors analyzed for p19Arf promoter hypermethylation, with methylation of identified transcription factor binding sites or consensus sequences occurring in 21 tumors (DMP1/Ets in two tumors, CTCF in four tumors, E2F in three tumors, Sp1 in 16 tumors). Two tumors contained point mutations in the p19Arf promoter. Nuclear staining for p19Arf was decreased by 80–100% in 41 of 71 (58%) tumors. The concordance between p19Arf molecular perturbations and altered protein expression was 63%. However, upon comparing p19Arf promoter perturbations (i.e. methylation of functional transcription factor binding sites and point mutations) and altered p19Arf expression, the concordance was 86%, suggesting a mechanism for changes in protein expression in some tumors. There was an absence of a mutually exclusive relationship between disruption of p53 and p19Arf, since the concordance was 62%. Similarly, no evidence was found of inverse relationships between perturbation of p16Ink4a and p19Arf (43% concordance) or p16Ink4a and p53 (37% concordance), suggesting that inactivation of these genes occurs independently and provides evidence that, although these genes may participate in cooperative cellular pathways, they also have functions in independent pathways that are important in mouse lung tumorigenesis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol PatholHome page
N. Wakamatsu, T. R. devereux, H.-H. L. Hong, and R. C. Sills
Overview of the Molecular Carcinogenesis of Mouse Lung Tumor Models of Human Lung Cancer
Toxicol Pathol, January 1, 2007; 35(1): 75 - 80.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. A. Belinsky
Silencing of genes by promoter hypermethylation: key event in rodent and human lung cancer
Carcinogenesis, September 1, 2005; 26(9): 1481 - 1487.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.